# A Prospective Multicenter Trial Evaluating Helios Biodegradable Polymer SES Safety and Effectiveness in CAD Treatment

Study · id `cardio:ct-nct01880879` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01880879](<https://clinicaltrials.gov/study/NCT01880879>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01880879

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 800 participants.

## Technical summary

Registry record NCT01880879. Allocation not applicable; no masking; primary purpose treatment. Start 2013-01 (registry gives no type); primary completion 2015-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 800 participants (planned count; ClinicalTrials.gov record NCT01880879, source copy `cardio:ctgov-nct01880879-2013-06-24`, retrieved 2026-10-26)
- Start date: 2013-01 (registry gives no type) (ClinicalTrials.gov record NCT01880879, source copy `cardio:ctgov-nct01880879-2013-06-24`, retrieved 2026-10-26)
- Primary completion: 2015-01 (anticipated) (ClinicalTrials.gov record NCT01880879, source copy `cardio:ctgov-nct01880879-2013-06-24`, retrieved 2026-10-26)
- Completion: 2015-01 (anticipated) (ClinicalTrials.gov record NCT01880879, source copy `cardio:ctgov-nct01880879-2013-06-24`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT01880879, source copy `cardio:ctgov-nct01880879-2013-06-24`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01880879-2013-06-24`, retrieved 2026-10-26)

## The registry's words

- Brief title: A Prospective Multicenter Trial Evaluating Helios Biodegradable Polymer SES Safety and Effectiveness in CAD Treatment
- Acronym: Pro-HOPE
- Condition: Coronary Artery Disease
- Intervention (Device): helios stent
- Lead sponsor: Kinhely Bio-tech Co., Ltd.
- Lead sponsor class: INDUSTRY
- Collaborator: RenJi Hospital
- Collaborator class: OTHER
- Collaborator: Peking University
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry lists this organization as a collaborator: RenJi Hospital (`cardio:org-renji-hospital`)
- Registry lists this organization as a collaborator: Peking University (`cardio:org-peking-university`)

## Provenance

Content hash: 8fb5581a97128fc4fab089b3f7a484d5385cf9678a4428e6300d03f99ec0eb31
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
